Table of Content

1 Tafenoquine Market Overview
1.1 Product Overview and Scope of Tafenoquine
1.2 Tafenoquine Segment by Type
1.2.1 Global Tafenoquine Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Powder
1.2.3 Pills
1.3 Tafenoquine Segment by Application
1.3.1 Tafenoquine Sales Comparison by Application: (2021-2027)
1.3.2 Radical Cure of P.vivax
1.3.3 P. falciparum Treatment
1.3.4 Prevention of Malaria Relapse
1.4 Global Tafenoquine Market Size Estimates and Forecasts
1.4.1 Global Tafenoquine Revenue 2016-2027
1.4.2 Global Tafenoquine Sales 2016-2027
1.4.3 Tafenoquine Market Size by Region: 2016 Versus 2021 Versus 2027

2 Tafenoquine Market Competition by Manufacturers
2.1 Global Tafenoquine Sales Market Share by Manufacturers (2016-2021)
2.2 Global Tafenoquine Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Tafenoquine Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Tafenoquine Manufacturing Sites, Area Served, Product Type
2.5 Tafenoquine Market Competitive Situation and Trends
2.5.1 Tafenoquine Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Tafenoquine Players Market Share by Revenue
2.5.3 Global Tafenoquine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Tafenoquine Retrospective Market Scenario by Region
3.1 Global Tafenoquine Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Tafenoquine Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Tafenoquine Market Facts & Figures by Country
3.3.1 North America Tafenoquine Sales by Country
3.3.2 North America Tafenoquine Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Tafenoquine Market Facts & Figures by Country
3.4.1 Europe Tafenoquine Sales by Country
3.4.2 Europe Tafenoquine Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Tafenoquine Market Facts & Figures by Region
3.5.1 Asia Pacific Tafenoquine Sales by Region
3.5.2 Asia Pacific Tafenoquine Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Tafenoquine Market Facts & Figures by Country
3.6.1 Latin America Tafenoquine Sales by Country
3.6.2 Latin America Tafenoquine Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Tafenoquine Market Facts & Figures by Country
3.7.1 Middle East and Africa Tafenoquine Sales by Country
3.7.2 Middle East and Africa Tafenoquine Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Tafenoquine Historic Market Analysis by Type
4.1 Global Tafenoquine Sales Market Share by Type (2016-2021)
4.2 Global Tafenoquine Revenue Market Share by Type (2016-2021)
4.3 Global Tafenoquine Price by Type (2016-2021)

5 Global Tafenoquine Historic Market Analysis by Application
5.1 Global Tafenoquine Sales Market Share by Application (2016-2021)
5.2 Global Tafenoquine Revenue Market Share by Application (2016-2021)
5.3 Global Tafenoquine Price by Application (2016-2021)

6 Key Companies Profiled
6.1 GlaxoSmithKline Pharmaceuticals (GSK)
6.1.1 GlaxoSmithKline Pharmaceuticals (GSK) Corporation Information
6.1.2 GlaxoSmithKline Pharmaceuticals (GSK) Description and Business Overview
6.1.3 GlaxoSmithKline Pharmaceuticals (GSK) Tafenoquine Sales, Revenue and Gross Margin (2016-2021)
6.1.4 GlaxoSmithKline Pharmaceuticals (GSK) Product Portfolio
6.1.5 GlaxoSmithKline Pharmaceuticals (GSK) Recent Developments/Updates
6.2 J & K Scientific LTD
6.2.1 J & K Scientific LTD Corporation Information
6.2.2 J & K Scientific LTD Description and Business Overview
6.2.3 J & K Scientific LTD Tafenoquine Sales, Revenue and Gross Margin (2016-2021)
6.2.4 J & K Scientific LTD Product Portfolio
6.2.5 J & K Scientific LTD Recent Developments/Updates
6.3 BOC Sciences
6.3.1 BOC Sciences Corporation Information
6.3.2 BOC Sciences Description and Business Overview
6.3.3 BOC Sciences Tafenoquine Sales, Revenue and Gross Margin (2016-2021)
6.3.4 BOC Sciences Product Portfolio
6.3.5 BOC Sciences Recent Developments/Updates
6.4 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd.
6.4.1 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Corporation Information
6.4.2 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Description and Business Overview
6.4.3 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Tafenoquine Sales, Revenue and Gross Margin (2016-2021)
6.4.4 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Product Portfolio
6.4.5 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Recent Developments/Updates
6.5 Pharmacodia (Beijing) Co.,Ltd
6.5.1 Pharmacodia (Beijing) Co.,Ltd Corporation Information
6.5.2 Pharmacodia (Beijing) Co.,Ltd Description and Business Overview
6.5.3 Pharmacodia (Beijing) Co.,Ltd Tafenoquine Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Pharmacodia (Beijing) Co.,Ltd Product Portfolio
6.5.5 Pharmacodia (Beijing) Co.,Ltd Recent Developments/Updates
6.6 Amadis Chemical Company Limited
6.6.1 Amadis Chemical Company Limited Corporation Information
6.6.2 Amadis Chemical Company Limited Description and Business Overview
6.6.3 Amadis Chemical Company Limited Tafenoquine Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Amadis Chemical Company Limited Product Portfolio
6.6.5 Amadis Chemical Company Limited Recent Developments/Updates
6.7 Merck
6.6.1 Merck Corporation Information
6.6.2 Merck Description and Business Overview
6.6.3 Merck Tafenoquine Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Merck Product Portfolio
6.7.5 Merck Recent Developments/Updates

7 Tafenoquine Manufacturing Cost Analysis
7.1 Tafenoquine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Tafenoquine
7.4 Tafenoquine Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Tafenoquine Distributors List
8.3 Tafenoquine Customers

9 Tafenoquine Market Dynamics
9.1 Tafenoquine Industry Trends
9.2 Tafenoquine Growth Drivers
9.3 Tafenoquine Market Challenges
9.4 Tafenoquine Market Restraints

10 Global Market Forecast
10.1 Tafenoquine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Tafenoquine by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Tafenoquine by Type (2022-2027)
10.2 Tafenoquine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Tafenoquine by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Tafenoquine by Application (2022-2027)
10.3 Tafenoquine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Tafenoquine by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Tafenoquine by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Tafenoquine Sales (Tons) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Tafenoquine Sales (Tons) Comparison by Application (2021-2027)
Table 3. Global Tafenoquine Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Tafenoquine Covered in This Study
Table 5. Global Tafenoquine Sales (Tons) of Key Manufacturers (2016-2021)
Table 6. Global Tafenoquine Sales Share by Manufacturers (2016-2021)
Table 7. Global Tafenoquine Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Tafenoquine Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Tafenoquine Average Price (US$/Gram) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Tafenoquine Manufacturing Sites and Area Served
Table 11. Manufacturers Tafenoquine Product Type
Table 12. Global Tafenoquine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Tafenoquine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tafenoquine as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Tafenoquine Sales by Region (2016-2021) & (Tons)
Table 16. Global Tafenoquine Sales Market Share by Region (2016-2021)
Table 17. Global Tafenoquine Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Tafenoquine Sales by Country (2016-2021) & (Tons)
Table 19. North America Tafenoquine Sales Market Share by Country (2016-2021)
Table 20. North America Tafenoquine Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Tafenoquine Revenue Market Share by Country (2016-2021)
Table 22. Europe Tafenoquine Sales by Country (2016-2021) & (Tons)
Table 23. Europe Tafenoquine Sales Market Share by Country (2016-2021)
Table 24. Europe Tafenoquine Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Tafenoquine Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Tafenoquine Sales by Region (2016-2021) & (Tons)
Table 27. Asia Pacific Tafenoquine Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Tafenoquine Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Tafenoquine Revenue Market Share by Region (2016-2021)
Table 30. Latin America Tafenoquine Sales by Country (2016-2021) & (Tons)
Table 31. Latin America Tafenoquine Sales Market Share by Country (2016-2021)
Table 32. Latin America Tafenoquine Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Tafenoquine Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Tafenoquine Sales by Country (2016-2021) & (Tons)
Table 35. Middle East and Africa Tafenoquine Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Tafenoquine Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Tafenoquine Revenue Market Share by Country (2016-2021)
Table 38. Global Tafenoquine Sales (Tons) by Type (2016-2021)
Table 39. Global Tafenoquine Sales Market Share by Type (2016-2021)
Table 40. Global Tafenoquine Revenue (Million US$) by Type (2016-2021)
Table 41. Global Tafenoquine Revenue Share by Type (2016-2021)
Table 42. Global Tafenoquine Price (US$/Gram) by Type (2016-2021)
Table 43. Global Tafenoquine Sales (Tons) by Application (2016-2021)
Table 44. Global Tafenoquine Sales Market Share by Application (2016-2021)
Table 45. Global Tafenoquine Revenue (Million US$) by Application (2016-2021)
Table 46. Global Tafenoquine Revenue Share by Application (2016-2021)
Table 47. Global Tafenoquine Price (US$/Gram) by Application (2016-2021)
Table 48. GlaxoSmithKline Pharmaceuticals (GSK) Corporation Information
Table 49. GlaxoSmithKline Pharmaceuticals (GSK) Description and Business Overview
Table 50. GlaxoSmithKline Pharmaceuticals (GSK) Tafenoquine Sales (Tons), Revenue (Million US$), Price (US$/Gram) and Gross Margin (2016-2021)
Table 51. GlaxoSmithKline Pharmaceuticals (GSK) Tafenoquine Product
Table 52. GlaxoSmithKline Pharmaceuticals (GSK) Recent Developments/Updates
Table 53. J & K Scientific LTD Corporation Information
Table 54. J & K Scientific LTD Description and Business Overview
Table 55. J & K Scientific LTD Tafenoquine Sales (Tons), Revenue (Million US$), Price (US$/Gram) and Gross Margin (2016-2021)
Table 56. J & K Scientific LTD Tafenoquine Product
Table 57. J & K Scientific LTD Recent Developments/Updates
Table 58. BOC Sciences Corporation Information
Table 59. BOC Sciences Description and Business Overview
Table 60. BOC Sciences Tafenoquine Sales (Tons), Revenue (Million US$), Price (US$/Gram) and Gross Margin (2016-2021)
Table 61. BOC Sciences Tafenoquine Product
Table 62. BOC Sciences Recent Developments/Updates
Table 63. WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Corporation Information
Table 64. WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Description and Business Overview
Table 65. WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Tafenoquine Sales (Tons), Revenue (Million US$), Price (US$/Gram) and Gross Margin (2016-2021)
Table 66. WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Tafenoquine Product
Table 67. WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Recent Developments/Updates
Table 68. Pharmacodia (Beijing) Co.,Ltd Corporation Information
Table 69. Pharmacodia (Beijing) Co.,Ltd Description and Business Overview
Table 70. Pharmacodia (Beijing) Co.,Ltd Tafenoquine Sales (Tons), Revenue (Million US$), Price (US$/Gram) and Gross Margin (2016-2021)
Table 71. Pharmacodia (Beijing) Co.,Ltd Tafenoquine Product
Table 72. Pharmacodia (Beijing) Co.,Ltd Recent Developments/Updates
Table 73. Amadis Chemical Company Limited Corporation Information
Table 74. Amadis Chemical Company Limited Description and Business Overview
Table 75. Amadis Chemical Company Limited Tafenoquine Sales (Tons), Revenue (Million US$), Price (US$/Gram) and Gross Margin (2016-2021)
Table 76. Amadis Chemical Company Limited Tafenoquine Product
Table 77. Amadis Chemical Company Limited Recent Developments/Updates
Table 78. Merck Corporation Information
Table 79. Merck Description and Business Overview
Table 80. Merck Tafenoquine Sales (Tons), Revenue (Million US$), Price (US$/Gram) and Gross Margin (2016-2021)
Table 81. Merck Tafenoquine Product
Table 82. Merck Recent Developments/Updates
Table 83. Production Base and Market Concentration Rate of Raw Material
Table 84. Key Suppliers of Raw Materials
Table 85. Tafenoquine Distributors List
Table 86. Tafenoquine Customers List
Table 87. Tafenoquine Market Trends
Table 88. Tafenoquine Growth Drivers
Table 89. Tafenoquine Market Restraints
Table 90. Global Tafenoquine Sales Forecast by Type (2022-2027) & (Tons)
Table 91. Global Tafenoquine Sales Market Share Forecast by Type (2022-2027)
Table 92. Global Tafenoquine Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 93. Global Tafenoquine Revenue Market Share Forecast by Type (2022-2027)
Table 94. Global Tafenoquine Sales Forecast by Application (2022-2027) & (Tons)
Table 95. Global Tafenoquine Sales Market Share Forecast by Application (2022-2027)
Table 96. Global Tafenoquine Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 97. Global Tafenoquine Revenue Market Share Forecast by Application (2022-2027)
Table 98. Global Tafenoquine Sales Forecast by Region (2022-2027) & (Tons)
Table 99. Global Tafenoquine Sales Market Share Forecast by Region (2022-2027)
Table 100. Global Tafenoquine Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 101. Global Tafenoquine Revenue Market Share Forecast by Region (2022-2027)
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Tafenoquine
Figure 2. Global Tafenoquine Market Share by Type in 2020 & 2027
Figure 3. Powder Product Picture
Figure 4. Pills Product Picture
Figure 5. Global Tafenoquine Market Share by Application in 2020 & 2027
Figure 6. Radical Cure of P.vivax
Figure 7. P. falciparum Treatment
Figure 8. Prevention of Malaria Relapse
Figure 9. Global Tafenoquine Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Tafenoquine Market Size 2016-2027 (US$ Million)
Figure 11. Global Tafenoquine Sales 2016-2027 (Tons)
Figure 12. Global Tafenoquine Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 13. Tafenoquine Sales Share by Manufacturers in 2020
Figure 14. Global Tafenoquine Revenue Share by Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Tafenoquine Players: Market Share by Revenue in 2020
Figure 16. Tafenoquine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 17. Global Tafenoquine Sales Market Share by Region (2016-2021)
Figure 18. Global Tafenoquine Sales Market Share by Region in 2020
Figure 19. Global Tafenoquine Revenue Market Share by Region (2016-2021)
Figure 20. Global Tafenoquine Revenue Market Share by Region in 2020
Figure 21. U.S. Tafenoquine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Canada Tafenoquine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Germany Tafenoquine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. France Tafenoquine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. U.K. Tafenoquine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Italy Tafenoquine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Russia Tafenoquine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. China Tafenoquine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Japan Tafenoquine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. South Korea Tafenoquine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. India Tafenoquine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Australia Tafenoquine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Taiwan Tafenoquine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Indonesia Tafenoquine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Thailand Tafenoquine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Malaysia Tafenoquine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Philippines Tafenoquine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Vietnam Tafenoquine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Mexico Tafenoquine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Brazil Tafenoquine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Argentina Tafenoquine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Turkey Tafenoquine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Saudi Arabia Tafenoquine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. UAE Tafenoquine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Sales Market Share of Tafenoquine by Type (2016-2021)
Figure 46. Sales Market Share of Tafenoquine by Application (2016-2021)
Figure 47. Sales Market Share of Tafenoquine by Application in 2020
Figure 48. Revenue Share of Tafenoquine by Application (2016-2021)
Figure 49. Revenue Share of Tafenoquine by Application in 2020
Figure 50. Manufacturing Cost Structure of Tafenoquine
Figure 51. Manufacturing Process Analysis of Tafenoquine
Figure 52. Tafenoquine Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed